HEADER HYDROLASE 29-OCT-21 7Q3Y TITLE STRUCTURE OF FULL-LENGTH, MONOMERIC, SOLUBLE SOMATIC ANGIOTENSIN I- TITLE 2 CONVERTING ENZYME SHOWING THE N- AND C-TERMINAL ELLIPSOID DOMAINS COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN-CONVERTING ENZYME; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ACE,DIPEPTIDYL CARBOXYPEPTIDASE I,KININASE II; COMPND 5 EC: 3.2.1.-,3.4.15.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: SOLUBLE SECRETED FORM OF HUMAN SOMATIC ANGIOTENSIN I- COMPND 9 CONVERTING ENZYME TERMINATING AT SER1211 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACE, DCP, DCP1; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: CHO-K1; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: EXPRESSION VECTOR; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCDNA3.1+ KEYWDS ZINC METALLOPROTEASE DICARBOXYPEPTIDASE GLYCOPROTEIN, HYDROLASE EXPDTA ELECTRON MICROSCOPY AUTHOR L.LUBBE,B.T.SEWELL,E.D.STURROCK REVDAT 3 24-AUG-22 7Q3Y 1 JRNL REVDAT 2 27-JUL-22 7Q3Y 1 JRNL REVDAT 1 20-JUL-22 7Q3Y 0 JRNL AUTH L.LUBBE,B.T.SEWELL,J.D.WOODWARD,E.D.STURROCK JRNL TITL CRYO-EM REVEALS MECHANISMS OF ANGIOTENSIN I-CONVERTING JRNL TITL 2 ENZYME ALLOSTERY AND DIMERIZATION. JRNL REF EMBO J. V. 41 10550 2022 JRNL REFN ESSN 1460-2075 JRNL PMID 35818993 JRNL DOI 10.15252/EMBJ.2021110550 REMARK 2 REMARK 2 RESOLUTION. 4.34 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : TOPAZ, EPU, CRYOSPARC, ISOLDE, REMARK 3 CRYOSPARC, CRYOSPARC, CRYOSPARC, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : FLEXIBLE FIT REMARK 3 REFINEMENT TARGET : CORRELATION COEFFICIENT REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 4.340 REMARK 3 NUMBER OF PARTICLES : 121372 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: CRYOSPARC NON-UNIFORM REFINEMENT WAS USED REMARK 4 REMARK 4 7Q3Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-NOV-21. REMARK 100 THE DEPOSITION ID IS D_1292118933. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : FULL-LENGTH, SOLUBLE, MONOMERIC REMARK 245 SOMATIC ANGIOTENSIN I- REMARK 245 CONVERTING ENZYME REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.50 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : DILUTED PROTEIN (IN BUFFER REMARK 245 CONTAINING ZINC CHLORIDE AND REMARK 245 SODIUM CHLORIDE) WAS INCUBATED REMARK 245 ON ICE FOR 30 MINUTES AFTER REMARK 245 WHICH IT WAS APPLIED TO THE REMARK 245 GRID, INCUBATED FOR 30 SECONDS, REMARK 245 AND BLOTTED FOR 3 SECONDS REMARK 245 BEFORE PLUNGING REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 11628 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 3000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4300.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 81000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7460 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 56300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 55.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G, H, I, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1202 REMARK 465 ARG A 1203 REMARK 465 SER A 1204 REMARK 465 GLU A 1205 REMARK 465 GLY A 1206 REMARK 465 PRO A 1207 REMARK 465 LEU A 1208 REMARK 465 PRO A 1209 REMARK 465 ASP A 1210 REMARK 465 SER A 1211 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 1041 H ILE A 1097 1.41 REMARK 500 H THR A 948 OD2 ASP A 953 1.50 REMARK 500 HG1 THR A 454 OD2 ASP A 462 1.51 REMARK 500 OD2 ASP A 443 H ILE A 499 1.51 REMARK 500 HG1 THR A 468 O ILE A 473 1.57 REMARK 500 OE2 GLU A 305 HG1 THR A 534 1.57 REMARK 500 HE1 TRP A 855 O ALA A 1086 1.58 REMARK 500 OE2 GLU A 77 HH21 ARG A 96 1.59 REMARK 500 OE1 GLN A 838 HD22 ASN A 1200 1.60 REMARK 500 O TRP A 40 HG1 THR A 44 1.60 REMARK 500 OD2 ASP A 1041 N ILE A 1097 2.09 REMARK 500 ND2 ASN A 648 O5 NAG B 1 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 130 48.92 -75.97 REMARK 500 PHE A 271 58.58 35.08 REMARK 500 SER A 457 2.25 -65.18 REMARK 500 GLU A 481 -8.41 -54.97 REMARK 500 PHE A 484 54.66 -152.18 REMARK 500 ASP A 563 5.74 -67.14 REMARK 500 TRP A 594 78.64 -152.28 REMARK 500 GLU A 699 -125.39 44.27 REMARK 500 PHE A 772 -26.90 -143.64 REMARK 500 PRO A 870 -176.92 -66.66 REMARK 500 LYS A 939 -32.42 -135.68 REMARK 500 ILE A1104 -63.69 -92.26 REMARK 500 TYR A1129 129.23 -37.91 REMARK 500 SER A1131 98.34 -69.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 361 NE2 REMARK 620 2 HIS A 365 NE2 87.8 REMARK 620 3 GLU A 389 OE1 95.6 88.0 REMARK 620 4 HOH A2001 O 107.7 146.6 118.7 REMARK 620 N 1 2 3 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-13797 RELATED DB: EMDB REMARK 900 STRUCTURE OF FULL-LENGTH, MONOMERIC, SOLUBLE SOMATIC ANGIOTENSIN I- REMARK 900 CONVERTING ENZYME SHOWING THE N- AND C-TERMINAL ELLIPSOID DOMAINS REMARK 900 RELATED ID: 7Q49 RELATED DB: PDB REMARK 900 7Q49 CONTAINS THE N-DOMAIN MODEL FROM LOCAL REFINEMENT OF THE FULL- REMARK 900 LENGTH, SOLUBLE, MONOMERIC SOMATIC ANGIOTENSIN I-CONVERTING ENZYME REMARK 900 RELATED ID: 7Q4C RELATED DB: PDB REMARK 900 7Q4C CONTAINS THE C-DOMAIN MODEL FROM LOCAL REFINEMENT OF THE FULL- REMARK 900 LENGTH, SOLUBLE, MONOMERIC SOMATIC ANGIOTENSIN I-CONVERTING ENZYME REMARK 900 RELATED ID: 7Q4D RELATED DB: PDB REMARK 900 7Q4D CONTAINS A MODEL OF THE TWO INTERACTING N-DOMAINS OF THE FULL- REMARK 900 LENGTH, SOLUBLE, DIMERIC ANGIOTENSIN I-CONVERTING ENZYME REMARK 900 RELATED ID: 7Q4E RELATED DB: PDB REMARK 900 7Q4E CONTAINS THE N-DOMAIN OF THE FULL-LENGTH, SOLUBLE, DIMERIC REMARK 900 ANGIOTENSIN I-CONVERTING ENZYME REMARK 900 RELATED ID: EMD-13799 RELATED DB: EMDB REMARK 900 EMD-13799 CONTAINS THE N-DOMAIN MAP FROM LOCAL REFINEMENT OF THE REMARK 900 CONSENSUS SOLUBLE, MONOMERIC SOMATIC ANGIOTENSIN I-CONVERTING REMARK 900 ENZYME MAP (EMD-13797) REMARK 900 RELATED ID: EMD-13801 RELATED DB: EMDB REMARK 900 EMD-13801 CONTAINS THE C-DOMAIN MAP FROM LOCAL REFINEMENT OF THE REMARK 900 CONSENSUS SOLUBLE, MONOMERIC SOMATIC ANGIOTENSIN I-CONVERTING REMARK 900 ENZYME MAP (EMD-13797) REMARK 900 RELATED ID: EMD-13802 RELATED DB: EMDB REMARK 900 EMD-13802 CONTAINS THE FULL-LENGTH, SOLUBLE, DIMERIC SOMATIC REMARK 900 ANGIOTENSIN I-CONVERTING ENZYME MAP FROM NON-UNIFORM REFINEMENT REMARK 900 RELATED ID: EMD-13803 RELATED DB: EMDB REMARK 900 EMD-13803 CONTAINS THE LOCAL REFINEMENT MAP OF THE TWO INTERACTING REMARK 900 N-DOMAINS OF FULL-LENGTH, SOLUBLE, DIMERIC SOMATIC ANGIOTENSIN I- REMARK 900 CONVERTING ENZYME USED AS INPUT FOR LOCAL REFINEMENT IN THIS ENTRY REMARK 900 RELATED ID: EMD-13804 RELATED DB: EMDB REMARK 900 EMD-13804 CONTAINS THE N-DOMAIN OF FULL-LENGTH, SOLUBLE, DIMERIC REMARK 900 SOMATIC ANGIOTENSIN I-CONVERTING ENZYME USED AS INPUT FOR LOCAL REMARK 900 REFINEMENT IN THIS ENTRY DBREF 7Q3Y A 1 1211 UNP P12821 ACE_HUMAN 30 1240 SEQADV 7Q3Y LEU A 576 UNP P12821 PRO 605 ENGINEERED MUTATION SEQRES 1 A 1211 LEU ASP PRO GLY LEU GLN PRO GLY ASN PHE SER ALA ASP SEQRES 2 A 1211 GLU ALA GLY ALA GLN LEU PHE ALA GLN SER TYR ASN SER SEQRES 3 A 1211 SER ALA GLU GLN VAL LEU PHE GLN SER VAL ALA ALA SER SEQRES 4 A 1211 TRP ALA HIS ASP THR ASN ILE THR ALA GLU ASN ALA ARG SEQRES 5 A 1211 ARG GLN GLU GLU ALA ALA LEU LEU SER GLN GLU PHE ALA SEQRES 6 A 1211 GLU ALA TRP GLY GLN LYS ALA LYS GLU LEU TYR GLU PRO SEQRES 7 A 1211 ILE TRP GLN ASN PHE THR ASP PRO GLN LEU ARG ARG ILE SEQRES 8 A 1211 ILE GLY ALA VAL ARG THR LEU GLY SER ALA ASN LEU PRO SEQRES 9 A 1211 LEU ALA LYS ARG GLN GLN TYR ASN ALA LEU LEU SER ASN SEQRES 10 A 1211 MET SER ARG ILE TYR SER THR ALA LYS VAL CYS LEU PRO SEQRES 11 A 1211 ASN LYS THR ALA THR CYS TRP SER LEU ASP PRO ASP LEU SEQRES 12 A 1211 THR ASN ILE LEU ALA SER SER ARG SER TYR ALA MET LEU SEQRES 13 A 1211 LEU PHE ALA TRP GLU GLY TRP HIS ASN ALA ALA GLY ILE SEQRES 14 A 1211 PRO LEU LYS PRO LEU TYR GLU ASP PHE THR ALA LEU SER SEQRES 15 A 1211 ASN GLU ALA TYR LYS GLN ASP GLY PHE THR ASP THR GLY SEQRES 16 A 1211 ALA TYR TRP ARG SER TRP TYR ASN SER PRO THR PHE GLU SEQRES 17 A 1211 ASP ASP LEU GLU HIS LEU TYR GLN GLN LEU GLU PRO LEU SEQRES 18 A 1211 TYR LEU ASN LEU HIS ALA PHE VAL ARG ARG ALA LEU HIS SEQRES 19 A 1211 ARG ARG TYR GLY ASP ARG TYR ILE ASN LEU ARG GLY PRO SEQRES 20 A 1211 ILE PRO ALA HIS LEU LEU GLY ASP MET TRP ALA GLN SER SEQRES 21 A 1211 TRP GLU ASN ILE TYR ASP MET VAL VAL PRO PHE PRO ASP SEQRES 22 A 1211 LYS PRO ASN LEU ASP VAL THR SER THR MET LEU GLN GLN SEQRES 23 A 1211 GLY TRP ASN ALA THR HIS MET PHE ARG VAL ALA GLU GLU SEQRES 24 A 1211 PHE PHE THR SER LEU GLU LEU SER PRO MET PRO PRO GLU SEQRES 25 A 1211 PHE TRP GLU GLY SER MET LEU GLU LYS PRO ALA ASP GLY SEQRES 26 A 1211 ARG GLU VAL VAL CYS HIS ALA SER ALA TRP ASP PHE TYR SEQRES 27 A 1211 ASN ARG LYS ASP PHE ARG ILE LYS GLN CYS THR ARG VAL SEQRES 28 A 1211 THR MET ASP GLN LEU SER THR VAL HIS HIS GLU MET GLY SEQRES 29 A 1211 HIS ILE GLN TYR TYR LEU GLN TYR LYS ASP LEU PRO VAL SEQRES 30 A 1211 SER LEU ARG ARG GLY ALA ASN PRO GLY PHE HIS GLU ALA SEQRES 31 A 1211 ILE GLY ASP VAL LEU ALA LEU SER VAL SER THR PRO GLU SEQRES 32 A 1211 HIS LEU HIS LYS ILE GLY LEU LEU ASP ARG VAL THR ASN SEQRES 33 A 1211 ASP THR GLU SER ASP ILE ASN TYR LEU LEU LYS MET ALA SEQRES 34 A 1211 LEU GLU LYS ILE ALA PHE LEU PRO PHE GLY TYR LEU VAL SEQRES 35 A 1211 ASP GLN TRP ARG TRP GLY VAL PHE SER GLY ARG THR PRO SEQRES 36 A 1211 PRO SER ARG TYR ASN PHE ASP TRP TRP TYR LEU ARG THR SEQRES 37 A 1211 LYS TYR GLN GLY ILE CYS PRO PRO VAL THR ARG ASN GLU SEQRES 38 A 1211 THR HIS PHE ASP ALA GLY ALA LYS PHE HIS VAL PRO ASN SEQRES 39 A 1211 VAL THR PRO TYR ILE ARG TYR PHE VAL SER PHE VAL LEU SEQRES 40 A 1211 GLN PHE GLN PHE HIS GLU ALA LEU CYS LYS GLU ALA GLY SEQRES 41 A 1211 TYR GLU GLY PRO LEU HIS GLN CYS ASP ILE TYR ARG SER SEQRES 42 A 1211 THR LYS ALA GLY ALA LYS LEU ARG LYS VAL LEU GLN ALA SEQRES 43 A 1211 GLY SER SER ARG PRO TRP GLN GLU VAL LEU LYS ASP MET SEQRES 44 A 1211 VAL GLY LEU ASP ALA LEU ASP ALA GLN PRO LEU LEU LYS SEQRES 45 A 1211 TYR PHE GLN LEU VAL THR GLN TRP LEU GLN GLU GLN ASN SEQRES 46 A 1211 GLN GLN ASN GLY GLU VAL LEU GLY TRP PRO GLU TYR GLN SEQRES 47 A 1211 TRP HIS PRO PRO LEU PRO ASP ASN TYR PRO GLU GLY ILE SEQRES 48 A 1211 ASP LEU VAL THR ASP GLU ALA GLU ALA SER LYS PHE VAL SEQRES 49 A 1211 GLU GLU TYR ASP ARG THR SER GLN VAL VAL TRP ASN GLU SEQRES 50 A 1211 TYR ALA GLU ALA ASN TRP ASN TYR ASN THR ASN ILE THR SEQRES 51 A 1211 THR GLU THR SER LYS ILE LEU LEU GLN LYS ASN MET GLN SEQRES 52 A 1211 ILE ALA ASN HIS THR LEU LYS TYR GLY THR GLN ALA ARG SEQRES 53 A 1211 LYS PHE ASP VAL ASN GLN LEU GLN ASN THR THR ILE LYS SEQRES 54 A 1211 ARG ILE ILE LYS LYS VAL GLN ASP LEU GLU ARG ALA ALA SEQRES 55 A 1211 LEU PRO ALA GLN GLU LEU GLU GLU TYR ASN LYS ILE LEU SEQRES 56 A 1211 LEU ASP MET GLU THR THR TYR SER VAL ALA THR VAL CYS SEQRES 57 A 1211 HIS PRO ASN GLY SER CYS LEU GLN LEU GLU PRO ASP LEU SEQRES 58 A 1211 THR ASN VAL MET ALA THR SER ARG LYS TYR GLU ASP LEU SEQRES 59 A 1211 LEU TRP ALA TRP GLU GLY TRP ARG ASP LYS ALA GLY ARG SEQRES 60 A 1211 ALA ILE LEU GLN PHE TYR PRO LYS TYR VAL GLU LEU ILE SEQRES 61 A 1211 ASN GLN ALA ALA ARG LEU ASN GLY TYR VAL ASP ALA GLY SEQRES 62 A 1211 ASP SER TRP ARG SER MET TYR GLU THR PRO SER LEU GLU SEQRES 63 A 1211 GLN ASP LEU GLU ARG LEU PHE GLN GLU LEU GLN PRO LEU SEQRES 64 A 1211 TYR LEU ASN LEU HIS ALA TYR VAL ARG ARG ALA LEU HIS SEQRES 65 A 1211 ARG HIS TYR GLY ALA GLN HIS ILE ASN LEU GLU GLY PRO SEQRES 66 A 1211 ILE PRO ALA HIS LEU LEU GLY ASN MET TRP ALA GLN THR SEQRES 67 A 1211 TRP SER ASN ILE TYR ASP LEU VAL VAL PRO PHE PRO SER SEQRES 68 A 1211 ALA PRO SER MET ASP THR THR GLU ALA MET LEU LYS GLN SEQRES 69 A 1211 GLY TRP THR PRO ARG ARG MET PHE LYS GLU ALA ASP ASP SEQRES 70 A 1211 PHE PHE THR SER LEU GLY LEU LEU PRO VAL PRO PRO GLU SEQRES 71 A 1211 PHE TRP ASN LYS SER MET LEU GLU LYS PRO THR ASP GLY SEQRES 72 A 1211 ARG GLU VAL VAL CYS HIS ALA SER ALA TRP ASP PHE TYR SEQRES 73 A 1211 ASN GLY LYS ASP PHE ARG ILE LYS GLN CYS THR THR VAL SEQRES 74 A 1211 ASN LEU GLU ASP LEU VAL VAL ALA HIS HIS GLU MET GLY SEQRES 75 A 1211 HIS ILE GLN TYR PHE MET GLN TYR LYS ASP LEU PRO VAL SEQRES 76 A 1211 ALA LEU ARG GLU GLY ALA ASN PRO GLY PHE HIS GLU ALA SEQRES 77 A 1211 ILE GLY ASP VAL LEU ALA LEU SER VAL SER THR PRO LYS SEQRES 78 A 1211 HIS LEU HIS SER LEU ASN LEU LEU SER SER GLU GLY GLY SEQRES 79 A 1211 SER ASP GLU HIS ASP ILE ASN PHE LEU MET LYS MET ALA SEQRES 80 A 1211 LEU ASP LYS ILE ALA PHE ILE PRO PHE SER TYR LEU VAL SEQRES 81 A 1211 ASP GLN TRP ARG TRP ARG VAL PHE ASP GLY SER ILE THR SEQRES 82 A 1211 LYS GLU ASN TYR ASN GLN GLU TRP TRP SER LEU ARG LEU SEQRES 83 A 1211 LYS TYR GLN GLY LEU CYS PRO PRO VAL PRO ARG THR GLN SEQRES 84 A 1211 GLY ASP PHE ASP PRO GLY ALA LYS PHE HIS ILE PRO SER SEQRES 85 A 1211 SER VAL PRO TYR ILE ARG TYR PHE VAL SER PHE ILE ILE SEQRES 86 A 1211 GLN PHE GLN PHE HIS GLU ALA LEU CYS GLN ALA ALA GLY SEQRES 87 A 1211 HIS THR GLY PRO LEU HIS LYS CYS ASP ILE TYR GLN SER SEQRES 88 A 1211 LYS GLU ALA GLY GLN ARG LEU ALA THR ALA MET LYS LEU SEQRES 89 A 1211 GLY PHE SER ARG PRO TRP PRO GLU ALA MET GLN LEU ILE SEQRES 90 A 1211 THR GLY GLN PRO ASN MET SER ALA SER ALA MET LEU SER SEQRES 91 A 1211 TYR PHE LYS PRO LEU LEU ASP TRP LEU ARG THR GLU ASN SEQRES 92 A 1211 GLU LEU HIS GLY GLU LYS LEU GLY TRP PRO GLN TYR ASN SEQRES 93 A 1211 TRP THR PRO ASN SER ALA ARG SER GLU GLY PRO LEU PRO SEQRES 94 A 1211 ASP SER HET NAG B 1 27 HET NAG B 2 27 HET BMA B 3 21 HET MAN B 4 22 HET NAG C 1 27 HET NAG C 2 28 HET NAG D 1 27 HET NAG D 2 28 HET NAG E 1 27 HET NAG E 2 27 HET BMA E 3 22 HET NAG F 1 27 HET NAG F 2 27 HET BMA F 3 20 HET MAN F 4 22 HET MAN F 5 22 HET NAG G 1 27 HET NAG G 2 27 HET BMA G 3 22 HET NAG H 1 27 HET NAG H 2 27 HET BMA H 3 22 HET NAG I 1 27 HET NAG I 2 27 HET BMA I 3 22 HET NAG J 1 26 HET NAG J 2 27 HET BMA J 3 20 HET MAN J 4 22 HET MAN J 5 22 HET FUC J 6 21 HET ZN A1301 1 HET CL A1302 1 HET NAG A1303 28 HET NAG A1304 28 HET NAG A1305 28 HET NAG A1306 28 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM ZN ZINC ION HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 2 NAG 22(C8 H15 N O6) FORMUL 2 BMA 7(C6 H12 O6) FORMUL 2 MAN 5(C6 H12 O6) FORMUL 10 FUC C6 H12 O5 FORMUL 11 ZN ZN 2+ FORMUL 12 CL CL 1- FORMUL 17 HOH *(H2 O) HELIX 1 AA1 ASP A 13 ASN A 45 1 33 HELIX 2 AA2 THR A 47 GLU A 77 1 31 HELIX 3 AA3 ILE A 79 PHE A 83 5 5 HELIX 4 AA4 ASP A 85 THR A 97 1 13 HELIX 5 AA5 LEU A 98 LEU A 103 5 6 HELIX 6 AA6 PRO A 104 ALA A 125 1 22 HELIX 7 AA7 PRO A 141 SER A 150 1 10 HELIX 8 AA8 SER A 152 GLY A 190 1 39 HELIX 9 AA9 ASP A 193 TRP A 201 1 9 HELIX 10 AB1 THR A 206 GLY A 238 1 33 HELIX 11 AB2 HIS A 251 GLY A 254 5 4 HELIX 12 AB3 TRP A 261 ASN A 263 5 3 HELIX 13 AB4 ILE A 264 VAL A 269 1 6 HELIX 14 AB5 VAL A 279 GLN A 286 1 8 HELIX 15 AB6 ASN A 289 LEU A 304 1 16 HELIX 16 AB7 PRO A 310 SER A 317 1 8 HELIX 17 AB8 THR A 352 LYS A 373 1 22 HELIX 18 AB9 PRO A 376 ARG A 380 5 5 HELIX 19 AC1 GLY A 386 THR A 401 1 16 HELIX 20 AC2 THR A 401 GLY A 409 1 9 HELIX 21 AC3 ASP A 417 ILE A 433 1 17 HELIX 22 AC4 ALA A 434 GLY A 452 1 19 HELIX 23 AC5 PRO A 455 SER A 457 5 3 HELIX 24 AC6 ARG A 458 GLY A 472 1 15 HELIX 25 AC7 PHE A 484 LYS A 489 5 6 HELIX 26 AC8 TYR A 498 ALA A 519 1 22 HELIX 27 AC9 PRO A 524 CYS A 528 5 5 HELIX 28 AD1 SER A 533 ALA A 546 1 14 HELIX 29 AD2 PRO A 551 VAL A 560 1 10 HELIX 30 AD3 ALA A 567 PHE A 574 1 8 HELIX 31 AD4 PHE A 574 GLY A 589 1 16 HELIX 32 AD5 ASP A 616 ASN A 648 1 33 HELIX 33 AD6 THR A 650 ARG A 676 1 27 HELIX 34 AD7 LYS A 677 PHE A 678 5 2 HELIX 35 AD8 ASP A 679 LEU A 683 5 5 HELIX 36 AD9 ASN A 685 GLN A 696 1 12 HELIX 37 AE1 LEU A 698 LEU A 703 5 6 HELIX 38 AE2 PRO A 704 ALA A 725 1 22 HELIX 39 AE3 PRO A 739 SER A 748 1 10 HELIX 40 AE4 LYS A 750 ILE A 769 1 20 HELIX 41 AE5 PHE A 772 ASN A 787 1 16 HELIX 42 AE6 ASP A 791 MET A 799 1 9 HELIX 43 AE7 SER A 804 GLY A 836 1 33 HELIX 44 AE8 TRP A 859 ASN A 861 5 3 HELIX 45 AE9 ILE A 862 VAL A 867 1 6 HELIX 46 AF1 ASP A 876 GLN A 884 1 9 HELIX 47 AF2 THR A 887 LEU A 902 1 16 HELIX 48 AF3 GLU A 910 SER A 915 1 6 HELIX 49 AF4 ASN A 950 TYR A 970 1 21 HELIX 50 AF5 PRO A 974 ARG A 978 5 5 HELIX 51 AF6 ASN A 982 SER A 996 1 15 HELIX 52 AF7 THR A 999 LEU A 1006 1 8 HELIX 53 AF8 SER A 1015 ILE A 1031 1 17 HELIX 54 AF9 ALA A 1032 ASP A 1049 1 18 HELIX 55 AG1 THR A 1053 GLU A 1055 5 3 HELIX 56 AG2 ASN A 1056 GLY A 1070 1 15 HELIX 57 AG3 PHE A 1082 LYS A 1087 5 6 HELIX 58 AG4 TYR A 1096 ALA A 1117 1 22 HELIX 59 AG5 PRO A 1122 CYS A 1126 5 5 HELIX 60 AG6 SER A 1131 LYS A 1143 1 13 HELIX 61 AG7 PRO A 1149 GLY A 1159 1 11 HELIX 62 AG8 ALA A 1165 HIS A 1186 1 22 SHEET 1 AA1 2 LYS A 126 VAL A 127 0 SHEET 2 AA1 2 TRP A 137 SER A 138 -1 O TRP A 137 N VAL A 127 SHEET 1 AA2 2 ILE A 248 PRO A 249 0 SHEET 2 AA2 2 ILE A 473 CYS A 474 1 O CYS A 474 N ILE A 248 SHEET 1 AA3 2 SER A 333 TRP A 335 0 SHEET 2 AA3 2 ARG A 344 LYS A 346 -1 O LYS A 346 N SER A 333 SHEET 1 AA4 2 VAL A 727 CYS A 728 0 SHEET 2 AA4 2 CYS A 734 LEU A 735 -1 O LEU A 735 N VAL A 727 SHEET 1 AA5 2 ILE A 846 PRO A 847 0 SHEET 2 AA5 2 LEU A1071 CYS A1072 1 O CYS A1072 N ILE A 846 SHEET 1 AA6 2 SER A 931 ASP A 934 0 SHEET 2 AA6 2 PHE A 941 LYS A 944 -1 O ARG A 942 N TRP A 933 SSBOND 1 CYS A 128 CYS A 136 1555 1555 2.03 SSBOND 2 CYS A 330 CYS A 348 1555 1555 2.03 SSBOND 3 CYS A 516 CYS A 528 1555 1555 2.03 SSBOND 4 CYS A 728 CYS A 734 1555 1555 2.03 SSBOND 5 CYS A 928 CYS A 946 1555 1555 2.03 SSBOND 6 CYS A 1114 CYS A 1126 1555 1555 2.03 LINK ND2 ASN A 9 C1 NAG E 1 1555 1555 1.45 LINK ND2 ASN A 25 C1 NAG F 1 1555 1555 1.43 LINK ND2 ASN A 45 C1 NAG I 1 1555 1555 1.43 LINK ND2 ASN A 82 C1 NAG A1306 1555 1555 1.44 LINK ND2 ASN A 117 C1 NAG G 1 1555 1555 1.44 LINK ND2 ASN A 289 C1 NAG J 1 1555 1555 1.43 LINK ND2 ASN A 416 C1 NAG A1305 1555 1555 1.44 LINK ND2 ASN A 480 C1 NAG H 1 1555 1555 1.44 LINK ND2 ASN A 648 C1 NAG B 1 1555 1555 1.44 LINK ND2 ASN A 666 C1 NAG A1303 1555 1555 1.44 LINK ND2 ASN A 685 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN A 731 C1 NAG D 1 1555 1555 1.44 LINK ND2 ASN A 913 C1 NAG A1304 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.43 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.44 LINK O6 BMA B 3 C1 MAN B 4 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.45 LINK O4 NAG E 2 C1 BMA E 3 1555 1555 1.44 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.44 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.45 LINK O3 BMA F 3 C1 MAN F 4 1555 1555 1.44 LINK O6 BMA F 3 C1 MAN F 5 1555 1555 1.44 LINK O4 NAG G 1 C1 NAG G 2 1555 1555 1.45 LINK O4 NAG G 2 C1 BMA G 3 1555 1555 1.44 LINK O4 NAG H 1 C1 NAG H 2 1555 1555 1.44 LINK O4 NAG H 2 C1 BMA H 3 1555 1555 1.45 LINK O4 NAG I 1 C1 NAG I 2 1555 1555 1.44 LINK O4 NAG I 2 C1 BMA I 3 1555 1555 1.45 LINK O4 NAG J 1 C1 NAG J 2 1555 1555 1.45 LINK O6 NAG J 1 C1 FUC J 6 1555 1555 1.43 LINK O4 NAG J 2 C1 BMA J 3 1555 1555 1.45 LINK O3 BMA J 3 C1 MAN J 4 1555 1555 1.44 LINK O6 BMA J 3 C1 MAN J 5 1555 1555 1.45 LINK NE2 HIS A 361 ZN ZN A1301 1555 1555 2.28 LINK NE2 HIS A 365 ZN ZN A1301 1555 1555 2.29 LINK OE1 GLU A 389 ZN ZN A1301 1555 1555 1.97 LINK ZN ZN A1301 O HOH A2001 1555 1555 2.05 CISPEP 1 ASP A 140 PRO A 141 0 -0.42 CISPEP 2 TYR A 607 PRO A 608 0 -0.15 CISPEP 3 GLU A 738 PRO A 739 0 -4.81 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000